VALERIE WHITE: Open Payments
NPI 1831147107 · DANVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,093 in 57 payments from 21 companies in 2025. Trend: 2023 $168 · 2024 $727 · 2025 $1,093
Food & beverage: $1,093
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $237 |
| Novo Nordisk Inc | 8 | $169 |
| PFIZER INC. | 7 | $141 |
| Esperion Therapeutics, Inc. | 4 | $70 |
| Supernus Pharmaceuticals, Inc. | 3 | $54 |
| Corcept Therapeutics | 2 | $48 |
| Alkermes, Inc. | 2 | $46 |
| Exact Sciences Corporation | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
Products named: VRAYLAR, NURTEC ODT, Wegovy, NEXLETOL, Rybelsus, UBRELVY, Qelbree, REXULTI.
Industry payments across VA — which companies pay providers there.
